Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization.
von Gegerfelt AS, Rosati M, Alicea C, Valentin A, Roth P, Bear J, Franchini G, Albert PS, Bischofberger N, Boyer JD, Weiner DB, Markham P, Israel ZR, Eldridge JH, Pavlakis GN, Felber BK. von Gegerfelt AS, et al. Among authors: bischofberger n. J Virol. 2007 Feb;81(4):1972-9. doi: 10.1128/JVI.01990-06. Epub 2006 Nov 29. J Virol. 2007. PMID: 17135321 Free PMC article.
Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment.
Lifson JD, Rossio JL, Arnaout R, Li L, Parks TL, Schneider DK, Kiser RF, Coalter VJ, Walsh G, Imming RJ, Fisher B, Flynn BM, Bischofberger N, Piatak M Jr, Hirsch VM, Nowak MA, Wodarz D. Lifson JD, et al. Among authors: bischofberger n. J Virol. 2000 Mar;74(6):2584-93. doi: 10.1128/jvi.74.6.2584-2593.2000. J Virol. 2000. PMID: 10684272 Free PMC article.
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment.
Lifson JD, Rossio JL, Piatak M Jr, Parks T, Li L, Kiser R, Coalter V, Fisher B, Flynn BM, Czajak S, Hirsch VM, Reimann KA, Schmitz JE, Ghrayeb J, Bischofberger N, Nowak MA, Desrosiers RC, Wodarz D. Lifson JD, et al. Among authors: bischofberger n. J Virol. 2001 Nov;75(21):10187-99. doi: 10.1128/JVI.75.21.10187-10199.2001. J Virol. 2001. PMID: 11581387 Free PMC article.
Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.
Ambrose Z, Palmer S, Boltz VF, Kearney M, Larsen K, Polacino P, Flanary L, Oswald K, Piatak M Jr, Smedley J, Shao W, Bischofberger N, Maldarelli F, Kimata JT, Mellors JW, Hu SL, Coffin JM, Lifson JD, KewalRamani VN. Ambrose Z, et al. Among authors: bischofberger n. J Virol. 2007 Nov;81(22):12145-55. doi: 10.1128/JVI.01301-07. Epub 2007 Sep 12. J Virol. 2007. PMID: 17855539 Free PMC article.
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques.
Rosenwirth B, ten Haaft P, Bogers WM, Nieuwenhuis IG, Niphuis H, Kuhn EM, Bischofberger N, Heeney JL, Uberla K. Rosenwirth B, et al. Among authors: bischofberger n. J Virol. 2000 Feb;74(4):1704-11. doi: 10.1128/jvi.74.4.1704-1711.2000. J Virol. 2000. PMID: 10644340 Free PMC article.
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans.
Igarashi T, Brown CR, Endo Y, Buckler-White A, Plishka R, Bischofberger N, Hirsch V, Martin MA. Igarashi T, et al. Among authors: bischofberger n. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):658-63. doi: 10.1073/pnas.98.2.658. Epub 2001 Jan 2. Proc Natl Acad Sci U S A. 2001. PMID: 11136236 Free PMC article.
82 results